The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP3484772
WO Application Number:
US2017042572
Type:
European Patent Granted for NL
Status:
Deemed not to be granted according to art. 52.4a or 52.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP17831681.6
WO Publication Number:
WO2018017561
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:
Dates
Filing date:
18/07/2017
Grant date:
20/12/2023
EP Publication Date:
22/05/2019
WO Publication Date:
25/01/2018
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
20/12/2023
EP B1 Publication Date:
20/12/2023
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
17/07/2037
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
20/12/2023
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
20/12/2023
Name:
Azurity Pharmaceuticals, Inc.
Address:
841 Woburn Street, Wilmington MA 01887, United States of America (US)
Inventor
1
Name:
GANDHI, Premal
Address:
Andover
MA 01810, United States of America (US)
2
Name:
NAGLE, James B.
Address:
Gloucester
MA 01930, United States of America (US)